DE69624143T2 - Phosphonsaurediester-derivate - Google Patents
Phosphonsaurediester-derivateInfo
- Publication number
- DE69624143T2 DE69624143T2 DE69624143T DE69624143T DE69624143T2 DE 69624143 T2 DE69624143 T2 DE 69624143T2 DE 69624143 T DE69624143 T DE 69624143T DE 69624143 T DE69624143 T DE 69624143T DE 69624143 T2 DE69624143 T2 DE 69624143T2
- Authority
- DE
- Germany
- Prior art keywords
- remedy
- phenyl
- lower alkyl
- phosphonsaurediester
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 Phosphonic acid diester Chemical class 0.000 abstract 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 208000002177 Cataract Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34090995 | 1995-12-27 | ||
| PCT/JP1996/003775 WO1997024360A1 (fr) | 1995-12-27 | 1996-12-24 | Derives de diester d'acide phosphonique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69624143D1 DE69624143D1 (de) | 2002-11-07 |
| DE69624143T2 true DE69624143T2 (de) | 2003-06-12 |
Family
ID=18341428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69624143T Expired - Lifetime DE69624143T2 (de) | 1995-12-27 | 1996-12-24 | Phosphonsaurediester-derivate |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5985858A (de) |
| EP (1) | EP0882730B1 (de) |
| JP (1) | JP3500468B2 (de) |
| KR (1) | KR100324866B1 (de) |
| CN (1) | CN1070863C (de) |
| AT (1) | ATE225357T1 (de) |
| AU (1) | AU702980B2 (de) |
| CA (1) | CA2241679C (de) |
| DE (1) | DE69624143T2 (de) |
| ES (1) | ES2181928T3 (de) |
| TW (1) | TW438806B (de) |
| WO (1) | WO1997024360A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4032193B2 (ja) * | 1998-04-24 | 2008-01-16 | 株式会社大塚製薬工場 | ホスホン酸ジエステル誘導体 |
| DK1112275T3 (da) | 1998-09-09 | 2003-11-24 | Metabasis Therapeutics Inc | Hidtil ukendte heteroaromatiske inhibitorer for fructose-1,6-bisphosphatase |
| IL149887A0 (en) * | 1999-12-22 | 2002-11-10 | Metabasis Therapeutics Inc | Novel bisamidate phosphonate prodrugs |
| US7563774B2 (en) * | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| BRPI0514372A (pt) * | 2004-08-18 | 2008-06-10 | Metabasis Therapeutics Inc | inibidores de tiazol de frutose 1, 6-bisfosfatase |
| US20100223162A1 (en) * | 2004-09-30 | 2010-09-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Supply-chain side assistance |
| US8704675B2 (en) * | 2004-09-30 | 2014-04-22 | The Invention Science Fund I, Llc | Obtaining user assistance |
| US9038899B2 (en) * | 2004-09-30 | 2015-05-26 | The Invention Science Fund I, Llc | Obtaining user assistance |
| US20100146390A1 (en) * | 2004-09-30 | 2010-06-10 | Searete Llc, A Limited Liability Corporation | Obtaining user assestance |
| US10445799B2 (en) | 2004-09-30 | 2019-10-15 | Uber Technologies, Inc. | Supply-chain side assistance |
| US10687166B2 (en) * | 2004-09-30 | 2020-06-16 | Uber Technologies, Inc. | Obtaining user assistance |
| US8762839B2 (en) * | 2004-09-30 | 2014-06-24 | The Invention Science Fund I, Llc | Supply-chain side assistance |
| US8341522B2 (en) * | 2004-10-27 | 2012-12-25 | The Invention Science Fund I, Llc | Enhanced contextual user assistance |
| US20060206817A1 (en) * | 2005-02-28 | 2006-09-14 | Jung Edward K | User assistance for a condition |
| US8282003B2 (en) * | 2004-09-30 | 2012-10-09 | The Invention Science Fund I, Llc | Supply-chain side assistance |
| US10514816B2 (en) | 2004-12-01 | 2019-12-24 | Uber Technologies, Inc. | Enhanced user assistance |
| US9098826B2 (en) * | 2004-09-30 | 2015-08-04 | The Invention Science Fund I, Llc | Enhanced user assistance |
| US20060075344A1 (en) * | 2004-09-30 | 2006-04-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Providing assistance |
| US9747579B2 (en) | 2004-09-30 | 2017-08-29 | The Invention Science Fund I, Llc | Enhanced user assistance |
| US9307577B2 (en) * | 2005-01-21 | 2016-04-05 | The Invention Science Fund I, Llc | User assistance |
| US20060090132A1 (en) * | 2004-10-26 | 2006-04-27 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Enhanced user assistance |
| US8358976B2 (en) | 2006-03-24 | 2013-01-22 | The Invention Science Fund I, Llc | Wireless device with an aggregate user interface for controlling other devices |
| US9552559B2 (en) | 2014-05-06 | 2017-01-24 | Elwha Llc | System and methods for verifying that one or more directives that direct transport of a second end user does not conflict with one or more obligations to transport a first end user |
| US10458801B2 (en) | 2014-05-06 | 2019-10-29 | Uber Technologies, Inc. | Systems and methods for travel planning that calls for at least one transportation vehicle unit |
| US9483744B2 (en) | 2014-05-06 | 2016-11-01 | Elwha Llc | Real-time carpooling coordinating systems and methods |
| US11100434B2 (en) | 2014-05-06 | 2021-08-24 | Uber Technologies, Inc. | Real-time carpooling coordinating system and methods |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS636089A (ja) * | 1986-06-27 | 1988-01-12 | Nippon Shokubai Kagaku Kogyo Co Ltd | 石炭−水スラリ−用分散剤 |
| JPH0651625B2 (ja) * | 1986-12-29 | 1994-07-06 | 株式会社大塚製薬工場 | 高脂質血症治療剤 |
| AU606808B2 (en) * | 1988-06-29 | 1991-02-14 | Otsuka Pharmaceutical Factory, Inc. | Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same |
| JPH0745508B2 (ja) * | 1988-06-29 | 1995-05-17 | 株式会社大塚製薬工場 | カルボン酸アミド誘導体 |
| EP0604657B1 (de) * | 1992-05-21 | 2000-01-12 | Otsuka Pharmaceutical Factory, Inc. | Phosphonsäurediester-derivat |
| JP2787407B2 (ja) * | 1992-06-19 | 1998-08-20 | 株式会社大塚製薬工場 | ホスホン酸ジエステル誘導体 |
| TW260664B (de) * | 1993-02-15 | 1995-10-21 | Otsuka Pharma Factory Inc | |
| JP3156026B2 (ja) * | 1993-12-27 | 2001-04-16 | 株式会社大塚製薬工場 | ホスホン酸ジエステル誘導体 |
| JP3109393B2 (ja) * | 1994-09-30 | 2000-11-13 | 双葉電子工業株式会社 | 可変周波数発生器 |
-
1996
- 1996-12-24 US US09/091,946 patent/US5985858A/en not_active Expired - Fee Related
- 1996-12-24 AU AU11734/97A patent/AU702980B2/en not_active Ceased
- 1996-12-24 DE DE69624143T patent/DE69624143T2/de not_active Expired - Lifetime
- 1996-12-24 KR KR1019980704945A patent/KR100324866B1/ko not_active IP Right Cessation
- 1996-12-24 ES ES96942639T patent/ES2181928T3/es not_active Expired - Lifetime
- 1996-12-24 AT AT96942639T patent/ATE225357T1/de not_active IP Right Cessation
- 1996-12-24 JP JP52417697A patent/JP3500468B2/ja not_active Expired - Fee Related
- 1996-12-24 CN CN96199436A patent/CN1070863C/zh not_active Expired - Fee Related
- 1996-12-24 CA CA002241679A patent/CA2241679C/en not_active Expired - Fee Related
- 1996-12-24 WO PCT/JP1996/003775 patent/WO1997024360A1/ja active IP Right Grant
- 1996-12-24 EP EP96942639A patent/EP0882730B1/de not_active Expired - Lifetime
- 1996-12-26 TW TW085116065A patent/TW438806B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU702980B2 (en) | 1999-03-11 |
| US5985858A (en) | 1999-11-16 |
| AU1173497A (en) | 1997-07-28 |
| EP0882730A4 (de) | 1999-04-28 |
| CA2241679A1 (en) | 1997-07-10 |
| ATE225357T1 (de) | 2002-10-15 |
| ES2181928T3 (es) | 2003-03-01 |
| EP0882730B1 (de) | 2002-10-02 |
| WO1997024360A1 (fr) | 1997-07-10 |
| TW438806B (en) | 2001-06-07 |
| JP3500468B2 (ja) | 2004-02-23 |
| CN1070863C (zh) | 2001-09-12 |
| EP0882730A1 (de) | 1998-12-09 |
| DE69624143D1 (de) | 2002-11-07 |
| KR19990076819A (ko) | 1999-10-15 |
| CN1206419A (zh) | 1999-01-27 |
| KR100324866B1 (ko) | 2002-10-19 |
| CA2241679C (en) | 2002-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69624143D1 (de) | Phosphonsaurediester-derivate | |
| DE69840755D1 (de) | Pyridazinderivate und diese als aktiven bestandteil enthaltende medikamente | |
| PT976748E (pt) | Derivados de pirrolidina com actividade inibidora de fosfolipase a2 | |
| EP1026149A4 (de) | Amidocarbonsäurederivate | |
| ATE358484T1 (de) | Antidiabetische medikamente | |
| PT916651E (pt) | DERIVADOS DE áCIDO FENILALQUILCARBOXILICO | |
| AU767923C (en) | Novel 2-(N-cyanoimino)thiazolidin-4-one derivatives | |
| PT947504E (pt) | Derivados de vitamina d 16-eno | |
| ATE380172T1 (de) | Benzylaminanalogen | |
| DK0882728T3 (da) | 1-methylcarbapenemderivater | |
| ES2140524T3 (es) | Derivados de metotrexato. | |
| DK0787710T3 (da) | Fluorpropenforbindelse, et insekticid indeholdende samme og et mellemprodukt til fremstilling deraf | |
| EP1197211A4 (de) | Wirkstoffe zur vorbeugung und behandlung von krebs | |
| DK1433480T3 (da) | Lægemiddel indeholdende pyrimidin-derivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |